Search - tctmd.com

Displaying 1 - 20 of 162

Sort: Relevancy | Date

Presentation TCT 2016

Case Presentation: BTK Intervention in Critical Limb Ischemia

Presenter: Bagrat Alekyan, Grzegorz L. Kaluza, Zaza Kavteladze

November 01, 2016

Presentation TCT 2016

What Makes a Plaque Vulnerable: Morphology, Chemistry, Biologic Activity, or Ischemia?

Presenter: John A. Ambrose, Peter H. Stone

November 01, 2016

Presentation TCT 2016

Local Ultrasound to Enhance Paclitaxel Delivery after Femoro-Popliteal Treatment in Critical Limb Ischemia: Immediate and Midterm Results of the PACUS Trial

Presenter: Michael D. Dake, Kenneth Rosenfield, Costantino Del Giudice

November 01, 2016

News Conference News TCT 2016

CMR Subanalysis of EXPLORE May Help Pinpoint Which CTO Regions Benefit From PCI

Yael L. Maxwell

November 01, 2016

Presentation TCT 2016

Strategy Trials: ISCHEMIA/EXCEL/FREEDOM: Strengths and Weaknesses

Presenter: Stuart J. Pocock, Jan G. P. Tijssen, David J. Cohen

November 01, 2016

Presentation TCT 2016

Critical Limb Ischemia: How to Develop a Comprehensive State-of-the-art Critical Limb Center

Presenter: George L Adams, John F Angle, Raghu Kolluri

October 31, 2016

Presentation TCT 2016

Debate: Should Most Patients With Anginal Chest Pain Undergo Angiography ± FFR? Yes For Definitive Diagnosis, and To Find and Treat Ischemia!

Presenter: Justin E. Davies, Ran Kornowski, Colin Berry

October 31, 2016

News Conference News TCT 2016

New BRS Studies Show Promise for Second-Generation Devices With Thinner Struts

Yael L. Maxwell

October 31, 2016

News Conference News TCT 2016

Cancer Patients Face Increased Risk of Acute MI, More PCI Complications, Higher Mortality, and Soaring Costs

Michael H. Wilson

October 31, 2016

Presentation TCT 2016

DEBATE: Predicting Thrombotic Events in Patients With STEMI and Multivessel Disease: The Degree of Stenosis/Ischemia Is Most Important!

Presenter: Ran Kornowski, Michel R. Le May, Anthony H. Gershlick

October 31, 2016

Presentation TCT 2016

TCT 18: Validation of Wound, Ischemia, Foot Ischemia (WIFI) classification System in Japanese Patients After Endovascular Treatment for Critical Limb Ischemia (CLI).

Presenter: Sriram S. Iyer, Craig M. Walker, Takahiro Tokuda

October 31, 2016

News Conference News TCT 2016

BIONICS: Ridaforolimus-Eluting Stent Noninferior to Zotarolimus Stent at 1 Year

TCT Daily Staff

October 30, 2016

Presentation TCT 2016

Rationale for and Design of ISCHEMIA: What I Expect the Findings to Be But What Wont Surprise Me!

Presenter: Jorge Gaspar, Bernard J. Gersh

October 30, 2016

Presentation TCT 2016

LIVE-IN-A-BOX CASE DEMONSTRATION: Mesentric Artery Intervention (Fibromuscular Dysplasia)

Presenter: Gary M. Ansel, Michael R. Jaff, D. Christopher Metzger

October 30, 2016

Presentation TCT 2016

Management of Visceral Artery Aneurysms: When to Intervene and How to Do It

Presenter: Gary M. Ansel, Michael R. Jaff, Constantino S. Pena

October 30, 2016

Presentation TCT 2016

Great Debate 1: The Optimal Management of Chronic Mesenteric Ischemia Is Catheter-based Intervention!

Presenter: Gary M. Ansel, Michael R. Jaff, Herbert D. Aronow

October 30, 2016

$TCT 1080: First-in-Man Prolonged Pressure-Controlled Intermittent Coronary Sinus Occlusion to Treat Refractory Left Ventricular Dysfunction and Ischemia$

Presentation TCT 2016

TCT 1080: First-in-Man Prolonged Pressure-Controlled Intermittent Coronary Sinus Occlusion to Treat Refractory Left Ventricular Dysfunction and Ischemia

Presenter: Tayo A. Addo, Jose de Ribamar Costa Jr, Francesco Giannini

October 30, 2016

Presentation TCT 2016

LIVE-IN-A-BOX CASE DEMONSTRATION: Renal Artery Intervention (Fibromuscular Dysplasia)

Presenter: Gary M. Ansel, Michael R. Jaff, D. Christopher Metzger

October 30, 2016

Presentation TCT 2016

Treatment of Renal Artery Fibromuscalar Dysplasia: Indications, Techniques, and Outcomes

Presenter: Gary M. Ansel, Michael R. Jaff, Mehdi H. Shishehbor

October 30, 2016

Presentation TCT 2016

Renal Artery Fibromuscular Dysplasia: Natural History and Treatment

Presenter: Gary M. Ansel, Michael R. Jaff

October 30, 2016

Advertisement

Case Presentation: BTK Intervention in Critical Limb Ischemia

What Makes a Plaque Vulnerable: Morphology, Chemistry, Biologic Activity, or Ischemia?

Local Ultrasound to Enhance Paclitaxel Delivery after Femoro-Popliteal Treatment in Critical Limb Ischemia: Immediate and Midterm Results of the PACUS Trial

CMR Subanalysis of EXPLORE May Help Pinpoint Which CTO Regions Benefit From PCI

Strategy Trials: ISCHEMIA/EXCEL/FREEDOM: Strengths and Weaknesses

Critical Limb Ischemia: How to Develop a Comprehensive State-of-the-art Critical Limb Center

Debate: Should Most Patients With Anginal Chest Pain Undergo Angiography ± FFR? Yes For Definitive Diagnosis, and To Find and Treat Ischemia!

New BRS Studies Show Promise for Second-Generation Devices With Thinner Struts

Cancer Patients Face Increased Risk of Acute MI, More PCI Complications, Higher Mortality, and Soaring Costs

DEBATE: Predicting Thrombotic Events in Patients With STEMI and Multivessel Disease: The Degree of Stenosis/Ischemia Is Most Important!

TCT 18: Validation of Wound, Ischemia, Foot Ischemia (WIFI) classification System in Japanese Patients After Endovascular Treatment for Critical Limb Ischemia (CLI).

BIONICS: Ridaforolimus-Eluting Stent Noninferior to Zotarolimus Stent at 1 Year

Rationale for and Design of ISCHEMIA: What I Expect the Findings to Be But What Wont Surprise Me!

LIVE-IN-A-BOX CASE DEMONSTRATION: Mesentric Artery Intervention (Fibromuscular Dysplasia)

Management of Visceral Artery Aneurysms: When to Intervene and How to Do It

Great Debate 1: The Optimal Management of Chronic Mesenteric Ischemia Is Catheter-based Intervention!

TCT 1080: First-in-Man Prolonged Pressure-Controlled Intermittent Coronary Sinus Occlusion to Treat Refractory Left Ventricular Dysfunction and Ischemia

LIVE-IN-A-BOX CASE DEMONSTRATION: Renal Artery Intervention (Fibromuscular Dysplasia)

Treatment of Renal Artery Fibromuscalar Dysplasia: Indications, Techniques, and Outcomes

Renal Artery Fibromuscular Dysplasia: Natural History and Treatment

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content